These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 32013974)
1. YAP and the RhoC regulator ARHGAP18, are required to mediate flow-dependent endothelial cell alignment. Coleman PR; Lay AJ; Ting KK; Zhao Y; Li J; Jarrah S; Vadas MA; Gamble JR Cell Commun Signal; 2020 Feb; 18(1):18. PubMed ID: 32013974 [TBL] [Abstract][Full Text] [Related]
2. Flow-dependent YAP/TAZ activities regulate endothelial phenotypes and atherosclerosis. Wang KC; Yeh YT; Nguyen P; Limqueco E; Lopez J; Thorossian S; Guan KL; Li YJ; Chien S Proc Natl Acad Sci U S A; 2016 Oct; 113(41):11525-11530. PubMed ID: 27671657 [TBL] [Abstract][Full Text] [Related]
3. Atheroprotective laminar flow inhibits Hippo pathway effector YAP in endothelial cells. Xu S; Koroleva M; Yin M; Jin ZG Transl Res; 2016 Oct; 176():18-28.e2. PubMed ID: 27295628 [TBL] [Abstract][Full Text] [Related]
4. Laminar flow inhibits the Hippo/YAP pathway via autophagy and SIRT1-mediated deacetylation against atherosclerosis. Yuan P; Hu Q; He X; Long Y; Song X; Wu F; He Y; Zhou X Cell Death Dis; 2020 Feb; 11(2):141. PubMed ID: 32081881 [TBL] [Abstract][Full Text] [Related]
5. The RhoGAP protein ARHGAP18/SENEX localizes to microtubules and regulates their stability in endothelial cells. Lovelace MD; Powter EE; Coleman PR; Zhao Y; Parker A; Chang GH; Lay AJ; Hunter J; McGrath AP; Jormakka M; Bertolino P; McCaughan G; Kavallaris M; Vadas MA; Gamble JR Mol Biol Cell; 2017 Apr; 28(8):1066-1078. PubMed ID: 28251925 [TBL] [Abstract][Full Text] [Related]
6. ARHGAP18: A Flow-Responsive Gene That Regulates Endothelial Cell Alignment and Protects Against Atherosclerosis. Lay AJ; Coleman PR; Formaz-Preston A; Ting KK; Roediger B; Weninger W; Schwartz MA; Vadas MA; Gamble JR J Am Heart Assoc; 2019 Jan; 8(2):e010057. PubMed ID: 30630384 [TBL] [Abstract][Full Text] [Related]
7. Atheroprotective effects of methotrexate via the inhibition of YAP/TAZ under disturbed flow. Liu D; Lv H; Liu Q; Sun Y; Hou S; Zhang L; Yang M; Han B; Wang G; Wang X; Du W; Nie H; Zhang R; Huang X; Hou J; Yu B J Transl Med; 2019 Nov; 17(1):378. PubMed ID: 31730006 [TBL] [Abstract][Full Text] [Related]
8. c-Abl regulates YAPY357 phosphorylation to activate endothelial atherogenic responses to disturbed flow. Li B; He J; Lv H; Liu Y; Lv X; Zhang C; Zhu Y; Ai D J Clin Invest; 2019 Mar; 129(3):1167-1179. PubMed ID: 30629551 [TBL] [Abstract][Full Text] [Related]
9. Advanced glycosylation end products (AGEs) controls proliferation, invasion and permeability through orchestrating ARHGAP18/RhoA pathway in human umbilical vein endothelial cells. Li X; Tao Y; Wang X; Wang T; Liu J Glycoconj J; 2020 Apr; 37(2):209-219. PubMed ID: 32016689 [TBL] [Abstract][Full Text] [Related]
10. ARHGAP18: an endogenous inhibitor of angiogenesis, limiting tip formation and stabilizing junctions. Chang GH; Lay AJ; Ting KK; Zhao Y; Coleman PR; Powter EE; Formaz-Preston A; Jolly CJ; Bower NI; Hogan BM; Rinkwitz S; Becker TS; Vadas MA; Gamble JR Small GTPases; 2014; 5(3):1-15. PubMed ID: 25425145 [TBL] [Abstract][Full Text] [Related]
11. DLC1 deficiency and YAP signaling drive endothelial cell contact inhibition of growth and tumorigenesis. Ritchey L; Ha T; Otsuka A; Kabashima K; Wang D; Wang Y; Lowy DR; Tosato G Oncogene; 2019 Nov; 38(45):7046-7059. PubMed ID: 31409902 [TBL] [Abstract][Full Text] [Related]
12. Caveolae control the anti-inflammatory phenotype of senescent endothelial cells. Powter EE; Coleman PR; Tran MH; Lay AJ; Bertolino P; Parton RG; Vadas MA; Gamble JR Aging Cell; 2015 Feb; 14(1):102-11. PubMed ID: 25407919 [TBL] [Abstract][Full Text] [Related]
13. Yes-associated protein (YAP) signaling regulates lipopolysaccharide-induced tissue factor expression in human endothelial cells. Yi L; Huang X; Guo F; Zhou Z; Dou Y; Huan J Surgery; 2016 May; 159(5):1436-48. PubMed ID: 26791271 [TBL] [Abstract][Full Text] [Related]
14. Harmine alleviates atherogenesis by inhibiting disturbed flow-mediated endothelial activation via protein tyrosine phosphatase PTPN14 and YAP. Yang Y; Ma Q; Li Z; Wang H; Zhang C; Liu Y; Li B; Wang Y; Cui Q; Xue F; Ai D; Zhu Y; He J Br J Pharmacol; 2021 Apr; 178(7):1524-1540. PubMed ID: 33474722 [TBL] [Abstract][Full Text] [Related]